Biphasic Levodopa-Induced Freezing of Gait in Parkinson's Disease

被引:8
|
作者
Nonnekes, Jorik [1 ,2 ]
Bloem, Bastiaan R. [3 ]
机构
[1] Radboud Univ Nijmegen, Ctr Expertise Parkinson & Movement Disorders, Donders Inst Brain Cognit & Behav, Med Ctr,Dept Rehabil, Nijmegen, Netherlands
[2] Sint Maartensklin, Dept Rehabil, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Ctr Expertise Parkinson & Movement Disorders, Med Ctr,Dept Neurol, Nijmegen, Netherlands
关键词
Gait; freezing of gait; levodopa; Parkinson's disease; parkinsonism; biphasic;
D O I
10.3233/JPD-201997
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The relation between freezing of gait in Parkinson's disease and levodopa is complex. Here, we describe a new phenotype of freezing of gait, namely levodopa-induced freezing of gait with a biphasic pattern. Our observation supports the idea that freezing of gait might emerge because of a mismatch between cognitive/limbic loops and motor loops involved in gait control. Moreover, it underscores the importance of assessing the influence of dopaminergic medication in daily clinical practice, including objective assessment in all three dopaminergic states. The possibility of biphasic freezing will only emerge after such a comprehensive evaluation, and will have immediate therapeutic consequences.
引用
收藏
页码:1245 / 1248
页数:4
相关论文
共 50 条
  • [1] "On" state freezing of gait in Parkinson disease A paradoxical levodopa-induced complication
    Espay, A. J.
    Fasano, A.
    van Nuenen, B. F. L.
    Payne, M. M.
    Snijders, A. H.
    Bloem, B. R.
    NEUROLOGY, 2012, 78 (07) : 454 - 457
  • [2] Controlled-release zolpidem improves freezing of gait and levodopa-induced dyskinesias in a patient with Parkinson's disease
    Barbosa, P.
    Fonoff, E.
    Ghilardi, M. G.
    MOVEMENT DISORDERS, 2023, 38 : S634 - S635
  • [3] Biphasic (Subtherapeutic) Levodopa-Induced Respiratory Dysfunction in Parkinson Disease
    van de Wetering-van Dongen, Veerle A.
    Espay, Alberto J.
    Marsili, Luca
    Sturchio, Andrea
    Ten Holter, Susanne
    Bloem, Bastiaan R.
    Nijkrake, Maarten J.
    NEUROLOGY-CLINICAL PRACTICE, 2021, 11 (04) : E402 - E406
  • [4] Levodopa-induced dyskinesia in Parkinson's disease
    Brotchie, JM
    Lee, J
    Venderova, K
    JOURNAL OF NEURAL TRANSMISSION, 2005, 112 (03) : 359 - 391
  • [5] Levodopa-induced migraine in Parkinson's disease
    Gunzler, S. A.
    MOVEMENT DISORDERS, 2013, 28 : S208 - S208
  • [6] Levodopa-induced hyperhomocysteinaemia in Parkinson's disease
    Yasui, K
    Nakaso, K
    Kowa, H
    Takeshima, T
    Nakashima, K
    ACTA NEUROLOGICA SCANDINAVICA, 2003, 108 (01): : 66 - 67
  • [7] Levodopa-induced dyskinesia in Parkinson’s disease
    J. M. Brotchie
    J. Lee
    K. Venderova
    Journal of Neural Transmission, 2005, 112 : 359 - 391
  • [8] Management of levodopa-induced dyskinesias in Parkinson's disease
    Kashihara, Kenichi
    JOURNAL OF NEUROLOGY, 2007, 254 (Suppl 5) : 27 - 31
  • [9] Levodopa-Induced Neurovascular Changes in Parkinson's Disease
    Jourdain, Vincent A.
    Tang, Chris C.
    Dhawan, Vijay
    Eidelberg, David
    ANNALS OF NEUROLOGY, 2015, 78 : S52 - S52
  • [10] Treatment of levodopa-induced dystonia in Parkinson's disease
    Pirtosek, Z
    5TH CONGRESS OF THE EUROPEAN SOCIETY FOR CLINICAL NEUROPHARMACOLOGY, 2000, : 193 - 200